CL King initiated coverage of TransMedics with a Buy rating and $161 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- Flutter initiated, SentinelOne upgraded: Wall Street’s top analyst calls
- Stephens starts TransMedics with an Overweight rating, $151 price target
- TransMedics initiated with an Overweight at Stephens
- TransMedics price target raised to $120 from $95 at Piper Sandler
- TransMedics price target raised to $117 from $102 at Canaccord